Calcitonin Gene-related Peptide Receptor Antagonist [EPC]

6969 reported adverse events

Drugs of this class: UBROGEPANT ATOGEPANT

These side effects are most commonly reported by patients taking drugs of the Calcitonin Gene-related Peptide Receptor Antagonist [EPC] class:

# Side effect Count
0 MIGRAINE 2018
1 DRUG INEFFECTIVE 1792
2 HEADACHE 1180
3 NAUSEA 1135
4 FATIGUE 790
5 CONSTIPATION 605
6 DIZZINESS 528
7 OFF LABEL USE 468
8 PAIN 438
9 VOMITING 391
See all common reactions for Calcitonin Gene-related Peptide Receptor Antagonist [EPC]

Drugs of the Calcitonin Gene-related Peptide Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MIGRAINE WITHOUT AURA 25 0.0833
1 MIGRAINE 2018 0.0211
2 BRAIN OPERATION 29 0.0127
3 MIGRAINE WITH AURA 29 0.0107
4 TENSION HEADACHE 42 0.0098
5 PRODUCT ADMINISTRATION INTERRUPTED 65 0.0083
6 THERAPEUTIC PRODUCT EFFECT DELAYED 30 0.0066
7 BRAIN FOG 94 0.0060
8 SPINAL OPERATION 65 0.0053
9 IMPAIRED GASTRIC EMPTYING 69 0.0051
See all enriched reactions for Calcitonin Gene-related Peptide Receptor Antagonist [EPC]